Merck touts expensive new COVID drug while dismissing cheap ivermectin
• https://www.wnd.com, By Art MooreThe announcement Friday by Merck that it plans to apply for emergency approval of a new experimental oral antiviral treatment for COVID-19 is of particular interest to many physicians who have been hindered or completely blocked from treating their C
